Evidence map›Paper›PMID 25228645›Full record

ArticleGenes & development2014

ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes.

Lisa D Boxer, Brook Barajas, Shiying Tao, Jiajing Zhang, Paul A Khavari

Open access · diamondAbstract read
In one paragraph

Article in Genes & development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 1 synthesis or guideline pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Squamous-state excursions activate APOBEC3A in cancer.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. ZNF750 Loss of Function Drives Spontaneous Psoriasiform Skin Inflammation.JID innovations : skin science from molecules to population health · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. CASZ1 Is Essential for Skin Epidermal Terminal Differentiation.The Journal of investigative dermatology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lisa D BoxerProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, California 94305, USA; Department of Biology, Stanford University, Stanford, California 94305, USA;
Brook BarajasProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, California 94305, USA;
Shiying TaoProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, California 94305, USA;
Jiajing ZhangProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, California 94305, USA;
Paul A KhavariProgram in Epithelial Biology, Stanford University School of Medicine, Stanford, California 94305, USA; Veterans Affairs Palo Alto Healthcare System, Palo Alto, California 94304, USA khavari@stanford.edu.
Stanford University · USVA Palo Alto Health Care System · US

Funding

REGULATORS OF EPIDERMAL GENE EXPRESSIONR01AR045192 · NIAMS · STANFORD UNIVERSITY · PI PAUL KHAVARI · 1999 to 2026
$9.9M
NIAMS NIH HHS R01 AR045192NIAMS NIH HHS R01 AR45192
6 · The paper itself

Abstract

ZNF750 controls epithelial homeostasis by inhibiting progenitor genes while inducing differentiation genes, a role underscored by pathogenic ZNF750 mutations in cancer and psoriasis. How ZNF750 accomplishes these dual gene regulatory impacts is unknown. Here, we characterized ZNF750 as a transcription factor that binds both the progenitor and differentiation genes that it controls at a CCNNAGGC DNA motif. ZNF750 interacts with the pluripotency transcription factor KLF4 and chromatin regulators RCOR1, KDM1A, and CTBP1/2 through conserved PLNLS sequences. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) and gene depletion revealed that KLF4 colocalizes ∼ 10 base pairs from ZNF750 at differentiation target genes to facilitate their activation but is unnecessary for ZNF750-mediated progenitor gene repression. In contrast, KDM1A colocalizes with ZNF750 at progenitor genes and facilitates their repression but is unnecessary for ZNF750-driven differentiation. ZNF750 thus controls differentiation in concert with RCOR1 and CTBP1/2 by acting with either KDM1A to repress progenitor genes or KLF4 to induce differentiation genes.

Indexed as

Gene Expression Regulation, DevelopmentalAlcohol OxidoreductasesAmino Acid MotifsCell DifferentiationCells, CulturedChromosome MappingCo-Repressor ProteinsDNA-Binding ProteinsHEK293 CellsHistone DemethylasesHumansKeratinocytesKruppel-Like Factor 4Kruppel-Like Transcription FactorsNerve Tissue ProteinsProtein BindingAlcohol OxidoreductasesCo-Repressor ProteinsCTBP2 protein, humanC-terminal binding proteinDNA-Binding ProteinsHistone DemethylasesKDM1A protein, humanKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsNerve Tissue ProteinsRCOR1 protein, humanRepressor ProteinsTranscription FactorsTumor Suppressor ProteinsZNF750 protein, humanchromatin regulatordifferentiationKLF4stem cellZNF750

Identifiers

PMID25228645
PMCPMC4173152
OpenAlexW2073396586

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.